Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.72 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.66 |
| ▸ | MAPT | P10636 | 1/20 | 0.66 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | MMP1 | P03956 | 1/20 | 0.55 |
| ▸ | MMP2 | P08253 | 1/20 | 0.55 |
| ▸ | MMP9 | P14780 | 1/20 | 0.55 |
| ▸ | MMP8 | P22894 | 1/20 | 0.55 |
| ▸ | MMP13 | P45452 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | F2 | P00734 | 1/20 | 0.52 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.52 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.52 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30414489 | 1.00 | POLB (0.72) | POLBSMN1; SMN2ALDH1A1MAPTMEN1 | |
| SCHEMBL9400292 | 0.88 | ALDH1A1 (0.70) | POLBSMN1; SMN2ALDH1A1MAPTMEN1 | |
| SCHEMBL11311669 | 0.86 | LMNA (0.59) | POLBSMN1; SMN2ALDH1A1MAPTMEN1 | |
| SCHEMBL9862155 | 0.86 | SMN1; SMN2 (0.63) | POLBSMN1; SMN2ALDH1A1MAPTMEN1 | |
| SCHEMBL11110731 | 0.85 | L3MBTL1 (0.56) | POLBSMN1; SMN2ALDH1A1MAPTMEN1 | |
| SCHEMBL7204676 | 0.85 | ALDH1A1 (0.77) | POLBSMN1; SMN2ALDH1A1MAPTKDM4E | |
| SCHEMBL13997417 | 0.83 | ALDH1A1 (0.68) | POLBSMN1; SMN2ALDH1A1MAPTMEN1 | |
| SCHEMBL6123467 | 0.82 | MAPT (0.61) | POLBSMN1; SMN2ALDH1A1MAPTMEN1 | |
| SCHEMBL939122 | 0.82 | POLB (0.63) | POLBSMN1; SMN2ALDH1A1MAPTMEN1 | |
| SCHEMBL11179508 | 0.81 | ALDH1A1 (0.66) | POLBSMN1; SMN2ALDH1A1MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 213 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116119833-B | Nutrient for water recovery system and preparation method and application thereof | 嘉兴沃特泰科环保科技股份有限公司 | 2023-09-08 | — | — | CN | claimed |
| CN-115403959-B | Preparation method of polarity-difference multicolor resin coating stock solution | 扬州市祥华新材料科技有限公司 | 2023-08-18 | — | — | CN | claimed |
| CN-116119833-A | Nutrient for water recovery system and preparation method and application thereof | 嘉兴沃特泰科环保科技股份有限公司 | 2023-05-16 | — | — | CN | claimed |
| CN-115403959-A | Preparation method of colorful resin coating stock solution with polarity difference | 扬州市祥华新材料科技有限公司 | 2022-11-29 | — | — | CN | claimed |
| US-9353051-B2 | Antiviral drugs for treatment or prevention of dengue infection | SIGA TECHNOLOGIES, INC. (US) | 2016-05-31 | — | — | US | claimed |
| CN-103159904-B | High-molecular polymer dye or pigment with adjustable color and preparation method thereof | SHANGHAI SUNVEA CHEMICAL INDUSTRY MATERIAL CO LTD | 2015-05-20 | — | — | CN | claimed |
| US-20130303491-A1 | Antiviral Drugs for Treatement or Prevention of Dengue Infection | SIGA TECHNOLOGIES INC. (US) | 2013-11-14 | — | — | US | claimed |
| US-8518960-B2 | Antiviral drugs for treatment or prevention of dengue infection | SIGA TECHNOLOGIES, INC. (US) | 2013-08-27 | — | — | US | claimed |
| CN-103159904-A | High-molecular polymer dye or pigment with adjustable color and preparation method thereof | SHANGHAI XUANYANG CHEMICAL MATERIAL SCIENCE & TECHNOLOGY CO LTD | 2013-06-19 | — | — | CN | claimed |
| US-20100189685-A1 | Antiviral Drugs for Treatment or Prevention of Dengue Infection | SIGA TECHNOLOGIES, INC. | 2010-07-29 | — | — | US | claimed |
| US-5766841-A | USING ENZYME | OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) | 1998-06-16 | — | — | US | claimed |
| EP-0566633-A4 | METHOD FOR VISUALLY DETECTING THE PRESENCE OF A VIRUS IN A CLINICAL SPECIMEN. | SYMEX CORP (US) | 1994-12-14 | — | — | EP | claimed |
| EP-0566633-A1 | METHOD FOR VISUALLY DETECTING THE PRESENCE OF A VIRUS IN A CLINICAL SPECIMEN | SYMEX CORP. (US) | 1993-10-27 | — | — | EP | claimed |
| US-5252458-A | Concentrating precipitating chromogen | SYMEX CORP. (US) | 1993-10-12 | — | — | US | claimed |
| WO-1993019143-A1 | COLORANT-CONTAINING ELECTRORHEOLOGICAL MATERIALS | LORD CORPORATION (US) | 1993-09-30 | — | — | WO | claimed |
| WO-1992012256-A1 | METHOD FOR VISUALLY DETECTING THE PRESENCE OF A VIRUS IN A CLINICAL SPECIMEN | SYMEX CORP. (US) | 1992-07-23 | — | — | WO | claimed |
| US-4965237-A | AROMATICITY-POSESSING ISOCYANATE COMPOUND, IMINO COMPOUND, AND ANILINE DERIVATIVE | MITSUBISHI PAPER MILLS, LTD. (JP) | 1990-10-23 | — | — | US | claimed |
| US-4510239-A | Double antibody immunoassays of enzymes such as prostatic acid phosphatase | BECKMAN INSTRUMENTS, INC. (US) | 1985-04-09 | — | — | US | claimed |
| US-4288362-A | Monoazo pigments containing a quinazo linonylacetoacetanilide coupling component | BAYER AKTIENGESELLSCHAFT (DE) | 1981-09-08 | — | — | US | claimed |
| US-3941768-A | One step diazotization coupling process | CIBA-GEIGY AG (CH) | 1976-03-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130303491-A1 | Antiviral Drugs for Treatement or Prevention of Dengue Infection | HAVCR2, EIF2AK2, ZC3HAV1 | POLB 3351/4885SMN1; SMN2 767/4885ALDH1A1 2277/4885 |
| US-20100189685-A1 | Antiviral Drugs for Treatment or Prevention of Dengue Infection | EIF2AK2, HAVCR2, SNRPE | POLB 2930/4885SMN1; SMN2 509/4885ALDH1A1 2072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.